Medical Expenditures Associated With Hypertension in the U.S., 2000–2013

American Journal of Preventive Medicine

Volumn 53, Issue 6, 2017, Pages S164-S171

  Zhang, Donglan ^a   Wang, Guijing ^b   Zhang, Ping ^b   Fang, Jing ^b   Ayala, Carma ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PRESCRIPTION DRUG;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT CARE; PRESCRIPTION; UNITED STATES; AGED; AMBULATORY CARE; COMORBIDITY; COST OF ILLNESS; ECONOMICS; HEALTH INSURANCE; HEALTH STATUS; PREVALENCE; STATISTICS AND NUMERICAL DATA; TRENDS; YOUNG ADULT;

ADULT; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; COST OF ILLNESS; FEMALE; HEALTH EXPENDITURES; HEALTH STATUS; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 85034763306     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2017.05.014     Document Type: Article

References (32)

1. Bauer, U.E., Briss, P.A., Goodman, R.A., Bowman, B.A., Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet 384:9937 (2014), 45–52, 10.1016/S0140-6736(14)60648-6.
2. Hajjar, I., Kotchen, T.A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290:2 (2003), 199–206, 10.1001/jama.290.2.199.
3. Yoon, S.S., Fryar, C.D., Carroll, M.D., Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief, 2015 No. 220 www.cdc.gov/nchs/data/databriefs/db220.pdf.
4. Yoon, S.S., Gu, Q., Nwankwo, T., Wright, J.D., Hong, Y., Burt, V., Trends in blood pressure among adults with hypertension United States, 2003 to 2012. Hypertension 65:1 (2015), 54–61, 10.1161/HYPERTENSIONAHA.114.04012.
5. Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135:10 (2017), e146–e603, 10.1161/CIR.0000000000000485.
6. Gu, Q., Burt, V.L., Dillon, C.F., Yoon, S., Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 126:17 (2012), 2105–2114, 10.1161/CIRCULATIONAHA.112.096156.
7. Agency for Healthcare Research and Quality. Statistical Brief #404: expenditures for hypertension among adults age 18 and older, 2010: estimates for the U.S. civilian noninstitutionalized population. https://meps.ahrq.gov/data_files/publications/st404/stat404.shtml. Published 2013.
8. D'Agostino, R.B., Vasan, R.S., Pencina, M.J., et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation 117:6 (2008), 743–753, 10.1161/CIRCULATIONAHA.107.699579.
9. Wang, G., Yan, L., Ayala, C., George, M.G., Fang, J., Hypertension-associated expenditures for medication among U.S. adults. Am J Hypertens 26:11 (2013), 1295–1302, 10.1093/ajh/hpt079.
10. Wang, G., Fang, J., Ayala, C., Hypertension-associated hospitalizations and costs in the United States, 1979–2006. Blood Press 23:2 (2014), 126–133, 10.3109/08037051.2013.814751.
11. Wilson, B.J., Watson, M.S., Prescott, G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ, 326(7394), 2003, 845, 10.1136/bmj.326.7394.845.
12. Zuvekas, S.H., Olin, G.L., Validating household reports of health care use in the medical expenditure panel survey. Health Serv Res 44:5, pt 1 (2009), 1679–1700, 10.1111/j.1475-6773.2009.00995.x.
13. Agency of Healthcare Research and Quality. Using appropriate price indices for analyses of health care expenditures or income across multiple years. https://meps.ahrq.gov/about_meps/Price_Index.shtml. Accessed August 2016.
14. Quan, H., Sundararajan, V., Halfon, P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:11 (2005), 1130–1139, 10.1097/01.mlr.0000182534.19832.83.
15. Manning, W.G., Mullahy, J., Estimating log models: to transform or not to transform?. J Health Econ 20:4 (2001), 461–494, 10.1016/S0167-6296(01)00086-8.
16. Mullahy, J., Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ 17:3 (1998), 247–281, 10.1016/S0167-6296(98)00030-7.
17. Buntin, M.B., Zaslavsky, A.M., Too much ado about two-part models and transformation?: comparing methods of modeling Medicare expenditures. J Health Econ 23:3 (2004), 525–542, 10.1016/j.jhealeco.2003.10.005.
18. MEPS-HC summary data tables: technical notes. 2013, Agency for Healthcare Research and Quality, Rockville, MD https://meps.ahrq.gov/survey_comp/hc_technical_notes.shtml.
19. Clabaugh, G., Ward, M.M., Cost of illness studies in the United States: a systematic review of methodologies used for direct cost. Value Health 11:1 (2008), 13–21, 10.1111/j.1524-4733.2007.00210.x.
20. National Cancer Insititute, Division of Cancer Control and Population Science. Joinpoint Trend Analysis Software. Version 4.3.1.0. https://surveillance.cancer.gov/joinpoint/. Published 2016.
21. Trogdon, J.G., Murphy, L.B., Khavjou, O.A., et al. Costs of chronic diseases at the state level: the Chronic Disease Cost Calculator. Prev Chronic Dis, 12, 2015, E131, 10.5888/pcd12.150131.
22. Hartman, M., Martin, A.B., Benson, J., Catlin, A., Team NHEA. National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration. Health Aff (Millwood) 32:1 (2013), 87–99, 10.1377/hlthaff.2012.1206.
23. Chobanian, A.V., Bakris, G.L., Black, H.R., et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:19 (2003), 2560–2571, 10.1001/jama.289.19.2560.
24. Branstetter, L.G., Chatterjee, C., Higgins, M., Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry. NBER Working Paper No 17188, 2011 Published June 2011.
25. Roebuck, M.C., Liberman, J.N., Gemmill-Toyama, M., Brennan, T.A., Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 30:1 (2011), 91–99, 10.1377/hlthaff.2009.1087.
26. Cuckler, G.A., Sisko, A.M., Keehan, S.P., et al. National health expenditure projections, 2012–22: slow growth until coverage expands and economy improves. Health Aff (Millwood) 32:10 (2013), 1820–1831, 10.1377/hlthaff.2013.0721.
27. Kannel, W.B., Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 14:2 (2000), 83–90, 10.1038/sj.jhh.1000949.
28. Lee, H.-Y., Oh, B.-H., Aging and arterial stiffness. Circ J 74:11 (2010), 2257–2262, 10.1253/circj.CJ-10-0910.
29. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;(133):1–8.
30. Albright, K., Boehme, A., Sen, B., et al. Stroke severity in men and women: what proportion of the disparity can be explained by differences in cardiovascular risk factors?. Stroke, 45(suppl 1), 2014, AWP121.
31. Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., et al. Forecasting the future of cardiovascular disease in the United States. Circulation 123:8 (2011), 933–944, 10.1161/CIR.0b013e31820a55f5.
32. Lau, D.T., Kasper, J.D., Potter, D., Lyles, A., Bennett, R.G., Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165:1 (2005), 68–74, 10.1001/archinte.165.1.68.